Does Potassium Chloride For Oral Solution Interact with Angiotensin Ii?
CDI records a major classification for Potassium Chloride For Oral Solution and Angiotensin Ii. The stored summary is: RAAS inhibitors that produce potassium retention; monitor for hyperkalemia with concomitant use. The mechanism involves inhibit aldosterone production, causing potassium retention. Patients taking both medications should consult their healthcare provider before starting, stopping, or changing the dosage of either drug. This record was extracted from drug labeling through openFDA. NIH/NLM RxNorm is used for drug identities. The summary and severity classification are CDI's processed information, not a verbatim source quotation. Product, route, and patient circumstances matter.
- Severity
- Major
- Angiotensin Ii Class
- Vasoconstrictor
- Management
- Close medical supervision required
- Data Source
- U.S. FDA via OpenFDA
Recorded Mechanism
Inhibit aldosterone production, causing potassium retention
What To Tell Your Doctor or Pharmacist
If you are taking Potassium Chloride For Oral Solution and your doctor is considering prescribing Angiotensin Ii (or vice versa), make sure to:
- Inform your doctor and pharmacist of all current medications, including over-the-counter drugs and supplements
- Ask whether the benefits of combining these medications outweigh the risks for your specific situation
- Ask what symptoms to watch for that would indicate the interaction is causing problems
- Ask how frequently you should be monitored while these are co-prescribed
- Ask whether any dosage adjustments are needed
- Never stop or change either medication without first consulting your healthcare provider